Combined Antiplatelet/Anticoagulant Drug for Cardiac Ischemia/Reperfusion Injury [1]
A review that may affect pharma strategy in the immediate future.
A review that may affect pharma strategy in the immediate future.
Links
[1] https://www.ctsnet.org/jans/combined-antiplateletanticoagulant-drug-cardiac-ischemiareperfusion-injury
[2] https://www.ctsnet.org/home/aprotopapas
[3] https://www.ahajournals.org/doi/pdf/10.1161/CIRCRESAHA.120.317450
[4] https://www.ctsnet.org/tags/basic-science
[5] https://www.ctsnet.org/taxonomy/molecular-biology
[6] https://www.ctsnet.org/taxonomy/pharmacology
[7] https://www.ctsnet.org/taxonomy/physiology
[8] https://www.ctsnet.org/tags/cardiac-pharmacology
[9] https://www.ctsnet.org/tags/cardiac-physiology
[10] https://www.ctsnet.org/taxonomy/intensive-care
[11] https://www.ctsnet.org/taxonomy/intensive-care-guidelines
[12] https://www.ctsnet.org/tags/pharmacology
[13] https://www.ctsnet.org/tags/physiology
[14] https://www.ctsnet.org/categories/cardiac
[15] https://www.ctsnet.org/categories/endovascular
[16] https://www.ctsnet.org/taxonomy2018/cardiac
[17] https://www.ctsnet.org/taxonomy2018/coronary-disease
[18] https://www.ctsnet.org/taxonomy2018/vascular
[19] https://www.ctsnet.org/taxonomy2018/endovascular
[20] https://www.ctsnet.org/taxonomy2018/basic-science